Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Arbor Centers for EyeCare is a Chicagoland ophthalmology and optometry practice that provides comprehensive eye care, diagnostic services, and surgical treatment. The practice focuses on cataract, glaucoma, diabetic retinopathy, age-related macular degeneration, corneal and refractive care, and oculoplastics, and it operates as part of the broader Chicago Arbor Eye Institute network. Arbor Centers for EyeCare was acquired by EyeSouth Partners in 2022, and its legacy brand has been combined with Chicago Eye Institute under the Chicago Arbor Eye Institute name. The organization is a healthcare services provider rather than a drug-development biotech company, with revenue generated from clinical care, outpatient procedures, and related eye-health services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Arbor Centers for EyeCare.